Fibronostics

We're live today at SOLAR 2026 in San Juan, Puerto Rico.

As conversations around steatosis, obesity, metabolic disease, and liver health continue to evolve, we're excited to join clinicians, researchers, industry partners, and patient advocates from around the world to discuss the latest advances in liver disease research and patient care.

SOLAR brings together key stakeholders across the liver disease ecosystem, providing an important platform for collaboration and scientific exchange as the field continues to advance.

Representing Fibronostics at the meeting are Brock Smith, Chief Executive Officer, and David Cashio, Director of Business Operations. We look forward to connecting with attendees and discussing the growing role of noninvasive liver assessment in supporting patients with MASLD and MASH.

If you're attending SOLAR 2026, we'd be delighted to meet and continue the conversation.

Today, we celebrate the fathers, father figures, and role models who bring the same dedication, patience, and care to their families as they do to our team.

At Fibronostics, we are grateful for the fathers among us who balance professional excellence with the important role of guiding, supporting, and inspiring the next generation.

Your commitment, resilience, and leadership make a difference both at work and at home.

To all the dads in our Fibronostics family and around the world, thank you for all that you do.

Happy Father's Day.